Breaking News

Waters Expands Executive Team

January 25, 2016

Newly formed executive committee to work closely with CEO

Waters Corp. has expanded its leadership structure with a newly formed executive committee, including five current executives who will assume broader responsibilities and work closely with president and chief executive officer Christopher J. O’Connell.
 
These changes coincide with Arthur G. Caputo's retirement and transition into a non-executive advisory role. Mr. Caputo has been with the company since 1977 and served as executive vice president and Waters Division president since 2002.
 
“Art is to be congratulated on a long and successful nearly 40-year career devoted to advancing Waters’ industry-leading technologies and global reach, and we are grateful for his countless contributions to our success,” said Mr. O'Connell. “Our new executive team will enable us to drive our business forward with great continuity, and enhance our strategic and operational capability. I have high confidence in our experienced team to execute our growth plan, and to accelerate the introduction of meaningful new innovations to market."
 
Current members of the executive committee will play enhanced global functional leadership roles: Mark T. Beaudouin, senior vice president, general counsel and secretary; Eugene G. Cassis, senior vice president and chief financial officer; Elizabeth B. Rae, senior vice President, global human resources.
 
Five executives have been promoted to the Executive Committee: Michael Harrington, senior vice president, Global Markets, responsible for global marketing, sales, and customer support operations; Terrance Kelly, senior vice president and president, TA Instruments, responsible for thermal analysis and rheology business operations; Rohit Khanna, senior vice president, Applied Technology, responsible for chemistry, informatics and service offerings; Ian S. King, senior vice president, Instrument Technology, responsible for separations and mass spectrometry instrument platforms; and David Terricciano, senior vice president, Global Operations, responsible for global quality, manufacturing and supply chain operations.

Related Packaging:

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent